Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsINJECTIONGeneric

CEPHALOTHIN SODIUM

CEPHALOTHIN SODIUM

Standard Dose
EQ 1GM BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued

Key Takeaways

  • Primary indication: Marketing status: Discontinued
  • Approval overview CEPHALOTHIN SODIUM is listed in Drugs@FDA under application 062666 (ANDA).
  • Marketing status: Discontinued Active ingredient CEPHALOTHIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 1GM BASE/VIAL Sponsor ABRAXIS PHARM Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview CEPHALOTHIN SODIUM is listed in Drugs@FDA under application 062666 (ANDA). Marketing status: Discontinued Active ingredient CEPHALOTHIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 1GM BASE/VIAL Sponsor ABRAXIS PHARM Submission history See approval history documents.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.